PRESS RELEASE

Cercare Medical Launches Version 16 of Neurosuite:
Showcasing Innovation at RSNA 2024 
CMN Version 16 delivers innovative capabilities for clinical and research use.
AARHUS, DENMARK, 2 Dec 2024: Cercare Medical, a global leader in advanced neuroimaging software, is proud to announce the release of CERCARE MEDICAL NEUROSUITE (CMN) Version 16.
This latest update introduces groundbreaking features designed to enhance diagnostic precision and efficiency in stroke and brain tumor management while advancing research capabilities.

Cercare Medical continues its mission to transform medical imaging through cutting-edge innovation. With Version 16, the company empowers healthcare professionals with unparalleled tools for both clinical and research use.

According to René Thomsen, CTO at Cercare Medical, “CMN Version 16 introduces a range of new features designed for stroke and oncology care. These include ASPECTS and DWI/FLAIR mismatch
for stroke evaluation, along with longitudinal tumor analysis for oncology. Together, these innovations underscore our commitment to enhancing diagnostic precision and streamlining workflows for clinicians and researchers.”
Key Highlights of CMN Version 16:
1. ASPECTS Improvement:
  • Improved Co-Registration: Enhancements ensure better co-registration for cases with significant rotation and thin-slice data, improving overall accuracy.

  • Enhanced M1-M6 Region Appearance: The M1-M6 regions now display without non-linear warping artifacts, ensuring consistent and accurate representation across subjects.

  • New ASPECTS Overview Montage: Introduces a montage featuring only two slices of the brain, available with and without the ASPECTS overlay. The montage also includes a table with intensity information, highlighting affected regions and providing the ASPECT scores for both hemispheres.

  • ICH Dependency Warning: A warning is now included in ASPECTS outputs if the ICH module detects bleeding. This guides the user to verify suspected bleeding and ensures ASPECTS is not used if bleeding is confirmed.

  • ASPECT Score in CMN DICOM Header: The ASPECT score is now added to the CMN DICOM header for easier reference and integration.

2. Configurable Fused, Montage, and Overlay Series
  • Fused Series: Combines any two series with adjustable overlay opacity, allowing for seamless export to PACS.

  • Montages: Displays the lesion overlaid on a series of anatomical images in a single image, incorporating all relevant quantitative lesion data.

  • Overlay Series: Overlays the lesion on a series of anatomical images in a scrollable format, enabling detailed analysis with all relevant quantitative lesion data.

3. Processing Multiple Series of the Same Sequence Type 
  • Supports analysis of diseases like Moyamoya by processing multiple series of the same sequence time (e.g., pre- and post-treatment DSC series).

  • Ensures distinction between derived series using Acquisition Date Time.

4. Speed Enhancements 
  • Optimization across workflows for faster processing.

5. DWI/FLAIR Mismatch for Stroke (Research Only) 
  • Enables advanced evaluation of wake-up strokes by identifying DWI/FLAIR mismatch, helping assess if the tissue is ischemic but salvageable.

6. Longitudinal Brain Tumor Lesion and VOI Analysis (Research Only)  
  • Comprehensive Longitudinal Analysis: CMN enables longitudinal analysis by comparing data from multiple studies of a patient. This includes insights into both lesion growth and perfusion changes over time.

  • Automatic VOI Analysis: Facilitates automatic Volume of Interest (VOI) analysis for segmented brain tumor lesions, streamlining research workflows.

  • Quantitative and Visual Insights: Generates detailed quantitative data and scrollable montages, offering a clear visualization of perfusion changes and lesion growth over time.

  • Customizable Map Inclusion: Allows the user to include any perfusion or diffusion map of interest in the VOI analysis, ensuring flexibility and relevance to specific research needs.

7. Flexible Licensing System 
  • Introducing a parameter-driven license system that allows mixing clinical and research features in the same license.

    Research outputs are clearly marked “not for clinical use,” enabling seamless use of clinically approved outputs alongside features and outputs intended for research only.

See CMN Version 16 in Action at RSNA 2024 
Cercare Medical will be exhibiting at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago Dec 1-4. This premier event provides an ideal platform to showcase the groundbreaking capabilities of CMN Version 16. “We look forward to demonstrating how our software enhances diagnostic precision and automated workflows, as well as engaging directly with clinical users to gather valuable feedback”, says Henrik Andersen, Chief Commercial Officer at Cercare Medical. At the RSNA show, Cercare Medical will provide live demonstrations of their software, showcasing how the company is shaping the future of neuroimaging. Visit the Cercare booth #7801 North Hall 3 to experience these demonstrations firsthand and learn more about the innovative advancements driving the future of neuroimaging
Setting New Standards in Clinical and Research Diagnostics 
Version 16 exemplifies Cercare Medical’s commitment to advancing neuroimaging for both clinical and research purposes. By integrating state-of-the-art tools like ASPECTS, configurable outputs and longitudinal analysis, CMN empowers users with unmatched flexibility and precision. 
About Cercare Medical:
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and
multi-vendor compatible software for CT and MRI perfusion imaging post-processing, we are
committed to delivering cutting-edge technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer's, Dementia, and COVID-19. Our proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging. This innovative technology has led to widespread adoption by leading hospitals and clinics around the world. 

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
© 2024 Cercare Medical. All rights reserved.

Request a demo

Let us give you a tour around our solution.

Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.



    TRY US!

    Seamless Upload & Analysis

    Upload your medical images securely for state of the art analysis.
    Discover how Cercare Medical Neurosuite can enhance your perfusion imaging post-processing.